JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maschauer, S.
Right arrow Articles by Kuwert, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maschauer, S.
Right arrow Articles by Kuwert, T.
Journal of Nuclear Medicine Vol. 45 No. 3 455-460
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Characterization of 18F-FDG Uptake in Human Endothelial Cells In Vitro

Simone Maschauer, Olaf Prante, PhD, Markus Hoffmann, J. Thiess Deichen, MD and Torsten Kuwert, MD

Department of Nuclear Medicine, Laboratory of Molecular Imaging, Friedrich-Alexander University, Erlangen, Germany

The contribution of 18F-FDG uptake by endothelial cells to uptake values measured by PET in various tissues is as yet unclear. We therefore sought to characterize 18F-FDG uptake in an in vitro model of human endothelial cells. Methods: Commercially obtained human umbilical vein endothelial cells (HUVECs) were seeded in 6-multiwell plates 48–96 h before incubation with 1–2 MBq 18F-FDG per well. Radioactivity measurements were performed after washing and mechanical dissolvation of the cellular monolayers. Cellular 18F-FDG uptake was referred to protein concentration. This experimental protocol was subsequently varied to study the effect of different parameters of interest. Furthermore, radio-thin-layer chromatography was used to identify intracellular 18F-FDG metabolites. 18F-FDG uptake in HUVECs was compared with that by a human monocyte–macrophage (HMM) preparation and by glioblastoma cells (GLIOs) under identical experimental conditions. Results: 18F-FDG accumulated in HUVECs in a time-dependent manner and was trapped mainly as 18F-FDG-6-phosphate and 18F-FDG-1,6-diphosphate. Unlabeled glucose and cytochalasin B competitively inhibited 18F-FDG uptake, whereas phlorizin had no significant effect. Glucose deprivation significantly enhanced 18F-FDG uptake by a factor of 2.7, whereas sodium depletion had no significant influence. HUVECs treated with vascular endothelial growth factor (VEGF) showed a significant 82% increase in 18F-FDG accumulation after a 2-h exposure to 50 ng/mL VEGF. 18F-FDG uptake in HUVECs was significantly higher than that in HMMs and in the range of the uptake values measured in GLIOs. Conclusion: 18F-FDG accumulates in HUVECs by mechanisms analogous to those in neoplastic cells or neurons. VEGF significantly stimulates endothelial 18F-FDG uptake. The observed differences in 18F-FDG uptake between HUVECs, HMMs, and GLIOs are difficult to extrapolate to in vivo conditions but stimulate further studies on the contribution of endothelial 18F-FDG uptake to the overall uptake of that tracer in neoplastic or vascular lesions.

Key Words: 18F-FDG • glucose transport • endothelium • human umbilical vein endothelial cells • vascular endothelial growth factor




This article has been cited by other articles:


Home page
JNMHome page
D. Blaser, S. Maschauer, T. Kuwert, and O. Prante
In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide
J. Nucl. Med., August 1, 2006; 47(8): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. K. Shankar, J. M. Hoffman, S. Bacharach, M. M. Graham, J. Karp, A. A. Lammertsma, S. Larson, D. A. Mankoff, B. A. Siegel, A. Van den Abbeele, et al.
Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
J. Nucl. Med., June 1, 2006; 47(6): 1059 - 1066.
[Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
M. M. Abouzied, E. S. Crawford, and H. A. Nabi
18F-FDG Imaging: Pitfalls and Artifacts
J. Nucl. Med. Technol., September 1, 2005; 33(3): 145 - 155.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J.-Y. Paik, K.-H. Lee, B.-H. Ko, Y. S. Choe, Y. Choi, and B.-T. Kim
Nitric Oxide Stimulates 18F-FDG Uptake in Human Endothelial Cells Through Increased Hexokinase Activity and GLUT1 Expression
J. Nucl. Med., February 1, 2005; 46(2): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. K. Buck and S. N. Reske
Cellular Origin and Molecular Mechanisms of 18F-FDG Uptake: Is There a Contribution of the Endothelium?
J. Nucl. Med., March 1, 2004; 45(3): 461 - 463.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.